Drug Index

NEORAL

Generic: CYCLOSPORINE

Review priority: STANDARD Marketing status: Discontinued

Route: ORAL
Class: General Medications
Safety profile: generic
Latest regulatory update: 26 Sept 2023, 12:00 am (UTC)

Structured Monograph

Approval overview NEORAL is listed in Drugs@FDA under application 050715 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CYCLOSPORINE Form and strength CAPSULE;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor NOVARTIS Submission history Latest submission status date: 2023-09-26 00:00:00. Submission type: SUPPL.